In contrast, STAMBP expression in the nuclei of tumor cells was downregulated in 51 patients (68%), unchanged in 12 patients (16.0%) and upregulated in 12 patients (16.0%) out of 75 patients compared with the corresponding noncancerous epithelial cells (Fig. 1D). Here, STAMBP is linked to neoplasm.